Back to Search
ALFRED HABEL, MD
MD
Pulmonary Disease Physician
NPI: 1760439608IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
38848(WI)
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
38848(WI)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
38848(WI)
Sleep Medicine (Internal Medicine) Physician
Internal Medicine — Sleep Medicine
Code: 207RS0012X
38848-20(WI)
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1990
Research & Publications (20)
Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2.
PMID 19429088·Neurosci Lett·2009
8-other
p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas.
PMID 19428789·Neurochem Int·2009
8-other
Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2.
PMID 19398149·Cancer Lett·2009
8-other
KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
PMID 19385057·Neurobiol Dis·2009
8-other
Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis.
PMID 19356600·Neurosci Lett·2009
8-other
Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.
PMID 19214542·Acta Neuropathol·2009
8-other
17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis.
PMID 19027068·Neurobiol Dis·2009
8-other
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
PMID 18971417·Neuro Oncol·2009
8-other
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.
PMID 18166586·J Exp Med·2008
7-preclinical
Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma.
PMID 18948169·Neurosci Lett·2008
8-other
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin.
PMID 18634847·Neurosci Lett·2008
8-other
Efficient and flexible synthesis of chiral gamma- and delta-lactones.
PMID 18421392·Org Biomol Chem·2008
8-other
The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.
PMID 19001439·Mol Cancer Ther·2008
8-other
Evidence for a radical mechanism of the dechlorination of chlorinated propenes mediated by the tetrachloroethene reductive dehalogenase of Sulfurospirillum muftivorans.
PMID 18044513·Environ Sci Technol·2007
8-other
1-phenylethyl isocyanate is a powerful reagent for the chiral analysis of secondary alcohols and hydroxy fatty acids with remote stereogenic centres.
PMID 17697687·J Chromatogr A·2007
8-other
Spinal cord ischemia after endovascular repair of the descending thoracic aorta in a sheep model.
PMID 17683959·Eur J Vasc Endovasc Surg·2007
7-preclinical
The nature of feeding in infants with unrepaired cleft lip and/or palate compared with healthy noncleft infants.
PMID 17477749·Cleft Palate Craniofac J·2007
4-observational
Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
PMID 17002542·Microb Drug Resist·2006
7-preclinical
Delayed detection of cleft palate: an audit of newborn examination.
PMID 16352626·Arch Dis Child·2006
4-observational
Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.
PMID 15388440·Antimicrob Agents Chemother·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6308 8TH AVE
KENOSHA, WI 53143 - Phone
- (262) 653-5360
Quick Facts
- NPI
- 1760439608
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile